Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth M Steinberg

Showing results (121-130 of 481) with videos related to

Pageof 49
Sort By:
Pharmacogenomics|November 25, 2016
Identification of novel SNPs associated with risk and prognosis in patients with castration-resistant prostate cancerTristan M Sissung, John Deeken, Crystal R Leibrand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2006
Proteomic analysis of malignant ovarian cancer effusions as a tool for biologic and prognostic profilingBen Davidson, Virginia Espina, Seth M Steinberg, et al.
Neuro-Oncology|May 3, 2018
Association of plexiform neurofibroma volume changes and development of clinical morbidities in neurofibromatosis 1Andrea M Gross, Gurbani Singh, Srivandana Akshintala, et al.
Pediatric Blood & Cancer|September 5, 2009
Clinical outcome in children with recurrent neuroblastoma treated with ABT-751 and effect of ABT-751 on proliferation of neuroblastoma cell lines and on tubulin polymerization in vitroHolly J Meany, Dan L Sackett, John M Maris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Anti-CD22 immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-positive hematologic malignancies of childhood: preclinical studies and phase I clinical trialAlan S Wayne, Robert J Kreitman, Harry W Findley, et al.
JAMA Dermatology|August 6, 2015
Efficacy of Intralesional Botulinum Toxin A for Treatment of Painful Cutaneous Leiomyomas: A Randomized Clinical TrialHaley B Naik, Seth M Steinberg, Lindsay A Middelton, et al.
Plos One|September 8, 2023
Clinical protocol: Feasibility of evaluating abemaciclib neuropharmacokinetics of diffuse midline glioma using intratumoral microdialysisEdjah K Nduom, John Glod, Desmond A Brown, et al.
Blood Advances|July 26, 2022
Doxorubicin pharmacokinetics and toxicity in patients with aggressive lymphoma and hepatic impairmentCatherine Lai, Diane E Cole, Seth M Steinberg, et al.
Cancer|October 5, 2002
Prospective analysis of circulating endostatin levels in patients with renal cell carcinomaAndrew L Feldman, H Richard Alexander, James C Yang, et al.
JTO Clinical and Research Reports|September 13, 2021
Tolerability of Coronavirus Disease 2019 Vaccines, BNT162b2 and mRNA-1273, in Patients With Thymic Epithelial TumorsMadison Ballman, Shannon Swift, Cristina Mullenix, et al.
Pageof 49

Showing results (121-130 of 481) with videos related to

Sort By:
Pageof 49
Pharmacogenomics|November 25, 2016
Identification of novel SNPs associated with risk and prognosis in patients with castration-resistant prostate cancerTristan M Sissung, John Deeken, Crystal R Leibrand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2006
Proteomic analysis of malignant ovarian cancer effusions as a tool for biologic and prognostic profilingBen Davidson, Virginia Espina, Seth M Steinberg, et al.
Neuro-Oncology|May 3, 2018
Association of plexiform neurofibroma volume changes and development of clinical morbidities in neurofibromatosis 1Andrea M Gross, Gurbani Singh, Srivandana Akshintala, et al.
Pediatric Blood & Cancer|September 5, 2009
Clinical outcome in children with recurrent neuroblastoma treated with ABT-751 and effect of ABT-751 on proliferation of neuroblastoma cell lines and on tubulin polymerization in vitroHolly J Meany, Dan L Sackett, John M Maris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Anti-CD22 immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-positive hematologic malignancies of childhood: preclinical studies and phase I clinical trialAlan S Wayne, Robert J Kreitman, Harry W Findley, et al.
JAMA Dermatology|August 6, 2015
Efficacy of Intralesional Botulinum Toxin A for Treatment of Painful Cutaneous Leiomyomas: A Randomized Clinical TrialHaley B Naik, Seth M Steinberg, Lindsay A Middelton, et al.
Plos One|September 8, 2023
Clinical protocol: Feasibility of evaluating abemaciclib neuropharmacokinetics of diffuse midline glioma using intratumoral microdialysisEdjah K Nduom, John Glod, Desmond A Brown, et al.
Blood Advances|July 26, 2022
Doxorubicin pharmacokinetics and toxicity in patients with aggressive lymphoma and hepatic impairmentCatherine Lai, Diane E Cole, Seth M Steinberg, et al.
Cancer|October 5, 2002
Prospective analysis of circulating endostatin levels in patients with renal cell carcinomaAndrew L Feldman, H Richard Alexander, James C Yang, et al.
JTO Clinical and Research Reports|September 13, 2021
Tolerability of Coronavirus Disease 2019 Vaccines, BNT162b2 and mRNA-1273, in Patients With Thymic Epithelial TumorsMadison Ballman, Shannon Swift, Cristina Mullenix, et al.
Pageof 49